Investitionsthese
Earlybird invests in early-stage tech companies with high growth potential, supporting them from idea to IPO with financial backing, strategic guidance, and a global network. Focuses on disruptive innovations in fintech, AI, health tech, and emerging technologies like nuclear fusion.
Investitionsphase
Pre-Seed to Series A
Bevorzugte Reifephase für die erste Finanzierung.
Sektoren & Themen
Tech-enabled companies across Europe
Thematische Schwerpunkte und Zielmarktsegmente von Interesse.
Ticketgröße
€12.000.000 - €12.000.000
Standard-Finanzierungsbetrag pro Runde.
Outreach & Dossier-Analysen
Verifiziertes E-Mail-Muster
Analysen-Scorecard der Investitionsthese
Unser KI-Analyzer hat Portfolio-Unternehmen gescannt und verifizierte Übereinstimmungen berechnet...
Investment Team (12)
A
Alexander Müller
Operating Partner
A
Andre Retterath
Partner
C
Christian Nagel
Partner & Co-Founder
D
Dr. John Yianni
Partner
F
Fabian Heilemann
Investment Professional
F
Florent Gros
Partner
G
Gregor Matthies
Associate Partner
L
Lionel Carnot
Partner
P
Paul Klemm
Partner
R
Rabab Nasrallah
Principal
R
Roland Manger
Founder and Partner
T
Thom Rasche
Managing Partner
